期刊
STEM CELLS
卷 27, 期 8, 页码 1954-1962出版社
WILEY
DOI: 10.1002/stem.118
关键词
Mesenchymal stem cells; Immunosuppression; Indoleamine 2,3-dioxygenase; Nitric oxide; Chemokine
资金
- New Jersey Commission on Science and Technology [NJCST-2042-014-84]
- Chinese Academy of Sciences
- National Institutes of Health [AI057596, AI50222]
- National Space Biomedical Research Institute [IIH00405]
- National Aeronautics and Space Administration through Cooperative Agreement [NCC 9-58]
Bone marrow-derived mesenchymal stem cells (MSCs) hold great promise for treating immune disorders because of their immunoregulatory capacity, but the mechanism remains controversial. As we show here, the mechanism of MSC-mediated immunosuppression varies among different species. Immunosuppression by human-or monkey-derived MSCs is mediated by indoleamine 2,3-dioxygenase (IDO), whereas mouse MSCs utilize nitric oxide, under the same culture conditions. When the expression of IDO and inducible nitric oxide synthase (iNOS) were examined in human and mouse MSCs after stimulation with their respective inflammatory cytokines, we found that human MSCs expressed extremely high levels of IDO, and very low levels of iNOS, whereas mouse MSCs expressed abundant iNOS and very little IDO. Immunosuppression by human MSCs was not intrinsic, but was induced by inflammatory cytokines and was chemokine-dependent, as it is in mouse. These findings provide critical information about the immunosuppression of MSCs and for better application of MSCs in treating immune disorders. STEM CELLS 2009;27:1954-1962
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据